Related Experiment Videos
Methylprednisolone pulse therapy induced fall in natural killer cell activity in rheumatoid arthritis
Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology
|October 1, 1984
Abstract:
Natural killer (NK) cell activity was studied in 8 patients with classic or definite rheumatoid arthritis (RA) by investigating the killing of K 562 cells by peripheral blood lymphocytes before, during, and after intravenous methylprednisolone pulse therapy (MPPT). MPPT produced a considerable fall in NK activity and after 3 months NK activity was less than half that before MPPT.
Insights
Methylprednisolone pulse therapy significantly reduced natural killer (NK) cell activity in rheumatoid arthritis (RA) patients. NK cell function remained suppressed for at least three months post-treatment.
Area of Science:
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Natural killer (NK) cells play a role in immune regulation.
- The impact of methylprednisolone pulse therapy (MPPT) on NK cell activity in RA requires further elucidation.
Purpose of the Study:
- To investigate the effect of MPPT on NK cell activity in patients with RA.
Main Methods:
- Studied NK cell activity in 8 RA patients.
- Assessed NK cell killing of K562 cells.
- Evaluated activity before, during, and after MPPT.
Main Results:
- MPPT caused a significant decrease in NK cell activity.
- NK cell activity was less than half of baseline levels at 3 months post-therapy.
Conclusions:
- MPPT profoundly suppresses NK cell activity in RA patients.
- This suppression persists for at least three months, suggesting a potential impact on immune surveillance.